Ubs Group Ag Soma Logic, Inc. Transaction History

Ubs Group Ag

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$1.76 - $2.83 $125,957 - $202,534	71,567 Added 62.08%	186,853 $472,000
Q3 2023 Nov 09, 2023	SELL	$1.99 - $2.45 $4,497 - $5,537	-2,260 Reduced 1.92%	115,286 $275,000
Q2 2023 Aug 11, 2023	BUY	$2.1 - $3.36 $96,387 - $154,220	45,899 Added 64.06%	117,546 $271,000
Q1 2023 May 12, 2023	BUY	$2.13 - $3.6 $25,853 - $43,696	12,138 Added 20.4%	71,647 $182,000
Q4 2022 Feb 08, 2023	BUY	$2.05 - $3.47 $101,483 - $171,778	49,504 Added 494.79%	59,509 $149,000
Q3 2022 Nov 10, 2022	SELL	$0.63 - $5.47 $6,892 - $59,841	-10,940 Reduced 52.23%	10,005 $29,000
Q2 2022 Aug 10, 2022	SELL	$4.27 - $8.26 $446,458 - $863,640	-104,557 Reduced 83.31%	20,945 $94,000
Q1 2022 May 16, 2022	BUY	$7.07 - $11.62 $820,042 - $1.35 Million	115,989 Added 1219.27%	125,502 $1.01 Million
Q4 2021 Feb 14, 2022	BUY	$10.49 - $14.28 $51,012 - $69,443	4,863 Added 104.58%	9,513 $110,000
Q3 2021 Nov 15, 2021	BUY	$9.94 - $12.77 $46,221 - $59,380	4,650 New	4,650 $58,000

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.